In Cd3e-deficient T-ALL, our data point to the down-regulation of Cdkn1a as part of the selective pressure to activate molecular mechanisms underlying the β-selection process and drive progression to T-ALL. The gene discussed is CD3E; the disease is acute lymphoblastic leukemia.